KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares Repurchased
Ratios

Vertex Pharmaceuticals (VRTX) Shares Repurchased (2018 - 2025)

Vertex Pharmaceuticals (VRTX) has 7 years of Shares Repurchased data on record, last reported at $128.4 million in Q4 2025.

  • For Q4 2025, Shares Repurchased fell 69.27% year-over-year to $128.4 million; the TTM value through Dec 2025 reached $2.0 billion, up 71.39%, while the annual FY2025 figure was $2.0 billion, 71.39% up from the prior year.
  • Shares Repurchased reached $128.4 million in Q4 2025 per VRTX's latest filing, down from $1.1 billion in the prior quarter.
  • Across five years, Shares Repurchased topped out at $1.1 billion in Q3 2025 and bottomed at $28.3 million in Q2 2023.
  • Average Shares Repurchased over 4 years is $336.5 million, with a median of $320.3 million recorded in 2024.
  • Peak YoY movement for Shares Repurchased: soared 1031.8% in 2024, then tumbled 69.27% in 2025.
  • A 4-year view of Shares Repurchased shows it stood at $368.2 million in 2021, then crashed by 59.4% to $149.5 million in 2023, then soared by 179.53% to $417.9 million in 2024, then crashed by 69.27% to $128.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Repurchased were $128.4 million in Q4 2025, $1.1 billion in Q3 2025, and $391.8 million in Q2 2025.